• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中冠状动脉微血管功能障碍评估中的微循环阻力指数

Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy.

作者信息

Aguiar Rosa Sílvia, Mota Carmo Miguel, Rocha Lopes Luís, Oliveira Eunice, Thomas Boban, Baquero Luis, Cruz Ferreira Rui, Fiarresga António

机构信息

Department of Cardiology, Hospital de Santa Marta, Lisbon, Portugal; Nova Medical School, Lisbon, Portugal; Heart Center, Hospital da Cruz Vermelha Portuguesa, Lisbon, Portugal.

Nova Medical School, Lisbon, Portugal.

出版信息

Rev Port Cardiol. 2022 Sep;41(9):761-767. doi: 10.1016/j.repc.2021.07.013. Epub 2022 Jul 20.

DOI:10.1016/j.repc.2021.07.013
PMID:36066271
Abstract

INTRODUCTION AND OBJECTIVES

Coronary microvascular dysfunction (CMD) is one of the most important pathophysiological features in hypertrophic cardiomyopathy (HCM). The index of microcirculatory resistance (IMR) is an invasive method to assess the coronary microcirculation. The aim was to assess CMD in patients with HCM by IMR.

METHODS

Adult patients with HCM without epicardial coronary artery disease underwent cardiac catheterization for the assessment of CMD by IMR (normal cut-off value ≤22.0) and coronary flow reserve (CFR) (normal cut-off value ≥2). Cardiovascular magnetic resonance (CMR) was performed to assess the ischemic burden by perfusion imaging during regadenoson-induced hyperemia, and the extent of myocardial fibrosis was assessed by late gadolinium enhancement (LGE), native T1 mapping and extracellular volume (ECV).

RESULTS

Fourteen patients were enrolled with a mean age of 62.8±6.2years, 8 (57.1%) males, of whom 9 (64.3%) had obstructive HCM. Using IMR, CMD was detected in 4 (29%) patients. Among four patients with an IMR>22.0, all had non-obstructive HCM and two had angina. CFR<2 was reported in eight patients (57%). Concordance between IMR and CFR (both normal or both abnormal) was verified in 6 patients (43%). Among four patients with IMR>22.0, perfusion defects were found in two of the three patients who underwent stress CMR. Increased ECV (>28%) was documented in two of the patients with IMR>22 and in three of the patients with IMR≤22.0. LGE was >15% in 2 of the patients with IMR>22 and in 4 with IMR≤22.0.

CONCLUSIONS

IMR assessment in HCM is feasible and safe. Patients with abnormal IMR seemed to have more significant tissue abnormalities on CMR.

摘要

引言与目的

冠状动脉微血管功能障碍(CMD)是肥厚型心肌病(HCM)最重要的病理生理特征之一。微循环阻力指数(IMR)是评估冠状动脉微循环的一种有创方法。本研究旨在通过IMR评估HCM患者的CMD。

方法

无冠状动脉疾病的成年HCM患者接受心脏导管检查,通过IMR(正常临界值≤22.0)和冠状动脉血流储备(CFR)(正常临界值≥2)评估CMD。采用心血管磁共振成像(CMR),通过瑞加诺生诱发充血期间的灌注成像评估缺血负荷,并通过延迟钆增强(LGE)、固有T1映射和细胞外容积(ECV)评估心肌纤维化程度。

结果

共纳入14例患者,平均年龄62.8±6.2岁,男性8例(57.1%),其中9例(64.3%)为梗阻性HCM。使用IMR检测到4例(29%)患者存在CMD。在IMR>22.0的4例患者中,均为非梗阻性HCM,2例有胸痛症状。8例(57%)患者报告CFR<2。6例(43%)患者IMR和CFR结果一致(均正常或均异常)。在IMR>22.0的4例患者中,3例接受负荷CMR检查的患者中有2例发现灌注缺损。IMR>22的2例患者和IMR≤22.0的3例患者记录到ECV增加(>28%)。IMR>22的2例患者和IMR≤22.0的4例患者LGE>15%。

结论

HCM患者进行IMR评估是可行且安全的。IMR异常的患者在CMR上似乎有更明显的组织异常。

相似文献

1
Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy.肥厚型心肌病中冠状动脉微血管功能障碍评估中的微循环阻力指数
Rev Port Cardiol. 2022 Sep;41(9):761-767. doi: 10.1016/j.repc.2021.07.013. Epub 2022 Jul 20.
2
Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance.使用心脏磁共振诊断微血管性心绞痛。
J Am Coll Cardiol. 2018 Mar 6;71(9):969-979. doi: 10.1016/j.jacc.2017.12.046.
3
Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.应激性心肌病的冠状动脉微血管功能障碍及其与左心室功能的关系。
ESC Heart Fail. 2023 Aug;10(4):2395-2405. doi: 10.1002/ehf2.14394. Epub 2023 May 22.
4
Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology.CMR 自动像素定量心肌灌注成像检测冠状动脉疾病和冠状动脉微血管功能障碍:与有创性冠状动脉生理学的对照验证。
JACC Cardiovasc Imaging. 2019 Oct;12(10):1958-1969. doi: 10.1016/j.jcmg.2018.12.022. Epub 2019 Feb 13.
5
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.
6
Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.肥厚型心肌病中冠状动脉微血管功能障碍的有创评估:微血管阻力指数
Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):426-8. doi: 10.1016/j.carrev.2015.06.008. Epub 2015 Jul 11.
7
Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.新型心脏磁共振参数“心肌通过时间”(MyoTT)评估心脏淀粉样变和肥厚型心肌病微血管改变的诊断价值。
Clin Res Cardiol. 2021 Jan;110(1):136-145. doi: 10.1007/s00392-020-01661-6. Epub 2020 May 5.
8
Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.钆剂-free 心脏磁共振负荷 T1 mapping 技术鉴别心外膜与微血管性冠心病。
J Am Coll Cardiol. 2018 Mar 6;71(9):957-968. doi: 10.1016/j.jacc.2017.11.071.
9
Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis.通过心脏磁共振节段分析发现肥厚型心肌病中灌注缺损、组织变化与心肌变形之间的关联。
Rev Port Cardiol. 2022 Jul;41(7):559-568. doi: 10.1016/j.repc.2022.03.003. Epub 2022 May 20.
10
Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR After STEMI Predicts Long-Term Outcomes.经皮冠状动脉介入治疗后通过压力导丝和 CMR 评估的冠状动脉微血管功能障碍可预测远期结局。
JACC Cardiovasc Imaging. 2021 Oct;14(10):1948-1959. doi: 10.1016/j.jcmg.2021.02.023. Epub 2021 Apr 14.

引用本文的文献

1
Prognostic Value of Coronary Angiography-Derived Index of Microvascular Resistance in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者冠状动脉造影衍生微血管阻力指数的预后价值
MedComm (2020). 2025 Jul 25;6(8):e70289. doi: 10.1002/mco2.70289. eCollection 2025 Aug.
2
A Systematic Approach to the Evaluation of the Coronary Microcirculation Using Bolus Thermodilution: CATH CMD.一种使用团注热稀释法评估冠状动脉微循环的系统方法:CATH CMD。
J Soc Cardiovasc Angiogr Interv. 2024 Apr 3;3(7):101934. doi: 10.1016/j.jscai.2024.101934. eCollection 2024 Jul.
3
Microcirculatory dysfunction in hypertrophic cardiomyopathy with chest pain assessed by angiography-derived microcirculatory resistance.
通过造影衍生的微血管阻力评估胸痛型肥厚型心肌病的微血管功能障碍。
Sci Rep. 2024 Jul 23;14(1):16977. doi: 10.1038/s41598-024-67979-7.